Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Massenkeil

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Oncology|November 1, 1996
Expression analyses of epidermal growth factor receptor and HER-2/neu: no advantage of prediction of recurrence or survival in breast cancer patientsM W Beckmann, D Niederacher, G Massenkeil, et al.
Bone Marrow Transplantation|August 20, 2008
Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapyT H Terwey, G Massenkeil, I Tamm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2010
Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and OncologyO Penack, D Buchheidt, M Christopeit, et al.
Arthritis Research|November 1, 2000
Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cellsO Rosen, A Thiel, G Massenkeil, et al.
Bone Marrow Transplantation|August 23, 2005
Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemiasG Massenkeil, M Nagy, S Neuburger, et al.
Bone Marrow Transplantation|April 25, 2001
Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathyO Rosen, G Massenkeil, F Hiepe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)M Sandherr, H Einsele, H Hebart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncologyW H Krüger, J Bohlius, O A Cornely, et al.
Leukemia|November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseR Arnold, G Massenkeil, M Bornhäuser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in EuropeL Barkholt, M Bregni, M Remberger, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Oncology|November 1, 1996
Expression analyses of epidermal growth factor receptor and HER-2/neu: no advantage of prediction of recurrence or survival in breast cancer patientsM W Beckmann, D Niederacher, G Massenkeil, et al.
Bone Marrow Transplantation|August 20, 2008
Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapyT H Terwey, G Massenkeil, I Tamm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2010
Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and OncologyO Penack, D Buchheidt, M Christopeit, et al.
Arthritis Research|November 1, 2000
Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cellsO Rosen, A Thiel, G Massenkeil, et al.
Bone Marrow Transplantation|August 23, 2005
Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemiasG Massenkeil, M Nagy, S Neuburger, et al.
Bone Marrow Transplantation|April 25, 2001
Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathyO Rosen, G Massenkeil, F Hiepe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)M Sandherr, H Einsele, H Hebart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncologyW H Krüger, J Bohlius, O A Cornely, et al.
Leukemia|November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseR Arnold, G Massenkeil, M Bornhäuser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in EuropeL Barkholt, M Bregni, M Remberger, et al.
Pageof 3